These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 35197774)

  • 1. AD-MSCs and BM-MSCs Ameliorating Effects on The Metabolic and Hepato-renal Abnormalities in Type 1 Diabetic Rats.
    El-Sawah SG; Rashwan HM; Althobaiti F; Aldhahrani A; Fayad E; Shabana ES; El-Hallous EI; Amen RM
    Saudi J Biol Sci; 2022 Feb; 29(2):1053-1060. PubMed ID: 35197774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Modulation of liver function, antioxidant responses, insulin resistance and glucose transport by Oroxylum indicum stem bark in STZ induced diabetic rats.
    Singh J; Kakkar P
    Food Chem Toxicol; 2013 Dec; 62():722-31. PubMed ID: 24140466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical efficacies, underlying mechanisms and molecular targets of Chinese medicines for diabetic nephropathy treatment and management.
    Tang G; Li S; Zhang C; Chen H; Wang N; Feng Y
    Acta Pharm Sin B; 2021 Sep; 11(9):2749-2767. PubMed ID: 34589395
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of diabetes mellitus on differentiation of mesenchymal stem cells into insulin-producing cells.
    Badr OI; Kamal MM; El-Maraghy SA; Ghaiad HR
    Biol Res; 2024 May; 57(1):20. PubMed ID: 38698488
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The tissue origin of human mesenchymal stem cells dictates their therapeutic efficacy on glucose and lipid metabolic disorders in type II diabetic mice.
    Ma Y; Wang L; Yang S; Liu D; Zeng Y; Lin L; Qiu L; Lu J; Chang J; Li Z
    Stem Cell Res Ther; 2021 Jul; 12(1):385. PubMed ID: 34233739
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anti-inflammation effect of Moutan Cortex on advanced glycation end products-induced rat mesangial cells dysfunction and High-glucose-fat diet and streptozotocin-induced diabetic nephropathy rats.
    Zhang MH; Feng L; Zhu MM; Gu JF; Jiang J; Cheng XD; Ding SM; Wu C; Jia XB
    J Ethnopharmacol; 2014; 151(1):591-600. PubMed ID: 24269777
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antioxidative Capacity of Liver- and Adipose-Derived Mesenchymal Stem Cell-Conditioned Media and Their Applicability in Treatment of Type 2 Diabetic Rats.
    Elshemy MM; Asem M; Allemailem KS; Uto K; Ebara M; Nabil A
    Oxid Med Cell Longev; 2021; 2021():8833467. PubMed ID: 33623636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of bone marrow-derived stem cells versus insulin on filiform and fungiform papillae of diabetic albino rats (light, fluorescent and scanning electron microscopic study).
    Mohsen ROM; Halawa AM; Hassan R
    Acta Histochem; 2019 Oct; 121(7):812-822. PubMed ID: 31358295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Therapeutic effect of N, N-Diphenyl-1,4-phenylenediamine and adipose-derived stem cells coadministration on diabetic cardiomyopathy in type 1 diabetes mellitus-rat model.
    Abd El-Lateef HM; Ali LS; Qahl SH; Binjawhar DN; Fayad E; Alghamdi MA; Altalhi SA; Al-Salmi FA; Shabana ES; Radwan KH; Youssef I; Shaaban S; Rashwan HM; El-Sawah SG
    J Exp Zool A Ecol Integr Physiol; 2024 Jul; 341(6):647-657. PubMed ID: 38594572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Do we really need to differentiate mesenchymal stem cells into insulin-producing cells for attenuation of the autoimmune responses in type 1 diabetes: immunoprophylactic effects of precursors to insulin-producing cells.
    Sharma A; Rani R
    Stem Cell Res Ther; 2017 Jul; 8(1):167. PubMed ID: 28701182
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allogeneic diabetic mesenchymal stem cells transplantation in streptozotocin-induced diabetic rat.
    Dong QY; Chen L; Gao GQ; Wang L; Song J; Chen B; Xu YX; Sun L
    Clin Invest Med; 2008 Dec; 31(6):E328-37. PubMed ID: 19032902
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficiency of Bone Marrow-Derived Mesenchymal Stem Cells and Hesperetin in the Treatment of Streptozotocin-Induced Type 1 Diabetes in Wistar Rats.
    Ahmed OM; Saleh AS; Ahmed EA; Ghoneim MM; Ebrahim HA; Abdelgawad MA; Abdel-Gabbar M
    Pharmaceuticals (Basel); 2023 Jun; 16(6):. PubMed ID: 37375806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Early intervention with mesenchymal stem cells prevents nephropathy in diabetic rats by ameliorating the inflammatory microenvironment.
    Li Y; Liu J; Liao G; Zhang J; Chen Y; Li L; Li L; Liu F; Chen B; Guo G; Wang C; Yang L; Cheng J; Lu Y
    Int J Mol Med; 2018 May; 41(5):2629-2639. PubMed ID: 29484379
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow stem cell-derived β-cells: New issue for diabetes cell therapy.
    Aglan HA; Kotob SE; Mahmoud NS; Kishta MS; Ahmed HH
    Tissue Cell; 2024 Feb; 86():102280. PubMed ID: 38029457
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of garlic on rats with chronic intermittent hypoxia combined with diabetes mellitus.
    Peng Y; Hu K
    Mol Med Rep; 2018 Apr; 17(4):6174-6184. PubMed ID: 29436658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human umbilical cord-derived mesenchymal stem cells prevent the progression of early diabetic nephropathy through inhibiting inflammation and fibrosis.
    Xiang E; Han B; Zhang Q; Rao W; Wang Z; Chang C; Zhang Y; Tu C; Li C; Wu D
    Stem Cell Res Ther; 2020 Aug; 11(1):336. PubMed ID: 32746936
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Umbilical Cord-Derived Mesenchymal Stem Cells Ameliorate Nephrocyte Injury and Proteinuria in a Diabetic Nephropathy Rat Model.
    Chen L; Xiang E; Li C; Han B; Zhang Q; Rao W; Xiao C; Wu D
    J Diabetes Res; 2020; 2020():8035853. PubMed ID: 32405507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Preliminary evaluation and mechanism of adipose-derived stem cell transplantation from allogenic diabetic rats in the treatment of diabetic rat wounds].
    Dong JY; Gong JH; Ji XY; Tian M; Liu YK; Qing C; Lu SL; Song F
    Zhonghua Shao Shang Za Zhi; 2019 Sep; 35(9):645-654. PubMed ID: 31594182
    [No Abstract]   [Full Text] [Related]  

  • 19. Mesenchymal stem cells: a future experimental exploration for recession of diabetic nephropathy.
    Hamza AH; Al-Bishri WM; Damiati LA; Ahmed HH
    Ren Fail; 2017 Nov; 39(1):67-76. PubMed ID: 27774826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal stem cells and differentiated insulin producing cells are new horizons for pancreatic regeneration in type I diabetes mellitus.
    Domouky AM; Hegab AS; Al-Shahat A; Raafat N
    Int J Biochem Cell Biol; 2017 Jun; 87():77-85. PubMed ID: 28385600
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.